1. Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX;
2. Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands;
3. Unit of Genomics of Complex Diseases, Institut d’Investigació Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain;
4. Cardiovascular Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden;
5. Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden;
6. Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Framingham, MA;
7. The Framingham Heart Study, Framingham, MA;
8. Center for Population Genomics, Veterans Affairs (VA) Boston Healthcare System, Jamaica Plain, MA;
9. Medical Research Council (MRC) Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom;
10. Department of Medical Sciences and
11. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden;
12. Department of Laboratory Medicine and Pathology, School of Medicine, University of Minnesota, Minneapolis, MN;
13. Department of Biostatistics, University of Washington, Seattle, WA;
14. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands;
15. Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany;
16. National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Chapel Hill, NC;
17. Department of Medicine, University of Washington, Seattle, WA;
18. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands;
19. Department of Epidemiology and Biostatistics and
20. Department of Stroke Medicine, Imperial College London, London, United Kingdom;
21. Institute of Nutrition, Friedrich Schiller University Jena, Mannheim, Germany;
22. Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands;
23. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN;
24. Royal North Shore Hospital, University of Sydney, Sydney, Australia;
25. Department of Neurology, Boston University, Boston, MA;
26. Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX;
27. Human Genome Sequencing Center, College of Medicine, Baylor University, Houston, TX;
28. MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom;
29. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA;
30. Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands;
31. Department of Neurology, School of Medicine, University of Maryland, Baltimore, MD;
32. Baltimore VA Medical Center, Baltimore, MD;
33. Department of Medicine,
34. Department of Epidemiology, and
35. Department of Health Services, University of Washington, Seattle, WA;
36. Kaiser Permanente Washington Research Institute, Kaiser Permanente Washington, Seattle, WA;
37. Fred Hutchinson Cancer Research Center, Seattle, WA;
38. Department of Epidemiology, University of Washington, Seattle, WA;
39. INSERM U1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France;
40. The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA;
41. Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX;
42. Synlab Academy, Synlab Holding Deutschland GmbH, Mannheim, Germany;
43. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria;
44. Einthoven Laboratory of Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands;
45. Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;
46. Unitat d’Hemostasia i Trombosi, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain;
47. MRC–Public Health England Centre for Environment and Health, School of Public Health and
48. UK Dementia Research Institute, Imperial College London, London, United Kingdom;
49. Cardiology Section, VA Boston Healthcare System, West Roxbury, MA; and
50. Seattle Epidemiologic Research and Information Center, Office of Research and Development, Department of Veteran Affairs, Seattle, WA